Search the Newsreel

Embecta Corp. 2026: Revenue $271.7M, EPS $0.36— 10-Q Summary

Embecta Corp. reported its 2026 quarter results with revenue of $271.7 million and diluted EPS of $0.36, marking a significant decrease from the prior year. The revenue decline was attributed to lower volume and pricing pressure, despite the acquisition of Owen Mumford. The company …

Earnings call transcript: Embecta beats Q3 2026 estimates, shares jump premarket

embecta Reports Third Quarter Fiscal 2026 Financial Results

Embecta Corp. announced its third-quarter fiscal 2026 financial results on August 7, 2026, holding a conference call and live webcast for analysts and investors. The company is transitioning from focusing solely on insulin delivery to becoming a broader medical supplies company. While the official …

Embecta reports Q3 FY2026 revenue $271.7M, GAAP net income $21.1M; raises adjusted EPS guidance

Embecta (EMBC) reported its Q3 FY2026 financial results, achieving revenues of $271.7 million and a GAAP net income of $21.1 million. The company posted adjusted diluted EPS of $0.56 and has raised its full-year adjusted operating margin and adjusted EPS guidance, while reaffirming full-year …

Embecta Corp. (Nasdaq: EMBC) Q3 2026 revenue dips as earnings outlook raised

embecta Sets Sept. 15 Payment Date for $0.01 Cash Dividend

embecta (Nasdaq: EMBC) has announced that its Board of Directors declared a quarterly cash dividend of $0.01 per share. The dividend is payable on September 15, 2026, to stockholders of record as of August 27, 2026. Following this news, EMBC's stock gained 27.29%, indicating …

embecta Announces Quarterly Cash Dividend

Embecta Corp. (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.01 per share. The dividend is payable on September 15, 2026, to stockholders of record as of August 27, 2026. Embecta is a global medical supplies company focused on insulin delivery and other …

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Embecta Corp. of Class Action Lawsuit and Upcoming Deadlines - EMBC

Pomerantz LLP has filed a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who suffered losses. The lawsuit alleges securities fraud after Embecta missed its Q2 2026 guidance and lowered its fiscal year guidance, primarily due to weak pen needle …

EMBC Investors Have Opportunity to Lead Embecta Corp. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) and its officers. The lawsuit alleges that Embecta made false and misleading statements about its business and operations, particularly concerning its pen needle business and fiscal guidance, leading …

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 17, 2026 in Embecta Corp. Lawsuit - EMBC

Levi & Korsinsky, LLP is reminding Embecta Corp. (NASDAQ: EMBC) investors of a pending class action lawsuit with a lead plaintiff deadline of August 17, 2026. The lawsuit alleges that Embecta made misleading statements regarding its fiscal year 2026 revenue guidance and U.S. pen …

Embecta Corp. (EMBC): Deeply Undervalued Global Medical Device Company

Embecta Corp. (EMBC), a global medical device company specializing in diabetes care, is highlighted as a potentially undervalued opportunity. Despite operating in a defensive healthcare sector with stable demand, EMBC trades at attractive valuation levels, boasting strong cash generation, resilient profitability, and an improving …

Levi & Korsinsky Reminds Embecta Corp. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 17, 2026 - EMBC

Levi & Korsinsky, LLP is reminding Embecta Corp. (NASDAQ: EMBC) investors of a pending class action lawsuit with a lead plaintiff deadline of August 17, 2026. The lawsuit alleges that Embecta made misleading statements regarding its fiscal year 2026 revenue guidance and U.S. pen …

Kaplan Fox Deadline Alert: Embecta Corp. (NASDAQ: EMBC) Investors Have Until August 17, 2026 to Seek a Lead Plaintiff Role

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit stems from a significant drop in Embecta's stock price after the …

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A

Bernstein Liebhard LLP has filed a securities class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased shares between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta made false and misleading statements about its business, leading …

EMBC UPCOMING DEADLINE : The Gross Law Firm Alerts Embecta Corp. Stockholders of Securities Class Action - Contact the Firm

The Gross Law Firm has issued a notice to shareholders of Embecta Corp. (NASDAQ: EMBC) regarding a securities class action lawsuit. The lawsuit alleges that Embecta made misleading statements about its financial performance, particularly concerning its pen needle business, leading to a significant stock …

EMBC Stock Drop: Embecta Insulin Pen Issues Lead to 57% Stock Drop and Securities Fraud Class Action for Investors

|

Deadline Alert: Embecta Corp. (EMBC) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Glancy Prongay Wolke & Rotter LLP is reminding investors of Embecta Corp. (EMBC) about an upcoming August 17, 2026 deadline to file a lead plaintiff motion in a class action lawsuit. The lawsuit alleges that Embecta made materially false and misleading statements between November …

EMBC Deadline: EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit

The Rosen Law Firm reminds investors who purchased Embecta Corp. (NASDAQ: EMBC) common stock between November 25, 2025, and May 4, 2026, of the upcoming August 17, 2026 lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that Embecta made misleading statements …

Embecta Corp. (EMBC) Faces Securities Class Action Over Insulin Pen Needle Disclosure - Investors with Losses Encouraged to Contact HBSS

Hagens Berman is investigating Embecta Corp. (EMBC) following a securities class action lawsuit alleging the company misrepresented the stability of its insulin pen needle business. The lawsuit claims Embecta's assurances of a "stable" business were false, as it was experiencing significant competitive share loss …

Embecta Corp. (NASDAQ:EMBC) Given Consensus Rating of "Reduce" by Analysts

Analysts have issued a consensus "Reduce" rating for Embecta Corp. (NASDAQ:EMBC), with an average 12-month price target of $11, though recent targets have been significantly lowered to $3-$5. The company recently reported weaker-than-expected Q1 earnings, missing EPS estimates and experiencing a 14.4% year-over-year revenue …

Embecta Corp. Revenue Breakdown – NASDAQ:EMBC

Embecta Corp. (NASDAQ: EMBC) outlines Owen Mumford deal terms and pro forma results

Embecta Corp. has outlined the detailed terms and pro forma financial results of its acquisition of Owen Mumford Holdings Limited, which was completed on May 15, 2026. The deal involved an upfront cash payment of £126.0 million ($166.1 million) and potential earn-out payments of …

Embecta (EMBC) Stock Drop: Robbins LLP Reminds Investors of Class Action and Urges Shareholders Who Lost Money to Contact the Firm

Robbins LLP has filed a securities class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased shares between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta misled investors about its financial outlook, particularly its pen needle …

Investors in Embecta Corp. (EMBC): Protect Your Rights - Contact Levi & Korsinsky Before August 17, 2026

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta made false and misleading statements about its financial …

Lost Money on Embecta Corp. (EMBC)? Join Class Action Suit Seeking Recovery - Contact SueWallSt

SueWallSt has announced a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit alleges false and misleading statements led to a 57.8% drop in Embecta's share value after …

EMBC INVESTOR ALERT: Embecta Corp. (EMBC) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- Hagens Berman

Hagens Berman has initiated an investigation into Embecta Corp. (EMBC) following a class action lawsuit alleging misrepresentation of the commercial stability of its insulin pen needle business. The lawsuit claims Embecta misled investors about market share loss and volume softness, which led to a …

Kaplan Fox Notifies Embecta Corp. (EMBC) Investors of a Securities Class Action Deadline on August 17, 2026

Kaplan Fox & Kilsheimer LLP has announced a securities class action lawsuit against Embecta Corp. (EMBC) for investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit stems from Embecta's Q2 fiscal 2026 results, which were significantly below expectations, leading …

EMBC Deadline Alert: Levi & Korsinsky Reminds Embecta Corp. (EMBC) Investors of Securities Class Action Deadline on August 17, 2026

Levi & Korsinsky, LLP is reminding investors of Embecta Corp. (NASDAQ: EMBC) about a securities class action lawsuit with a lead plaintiff deadline of August 17, 2026. The lawsuit alleges that Embecta made misrepresentations regarding the stability of its U.S. pen needle revenue, which …

Portnoy Law Firm Announces Class Action on Behalf of Embecta Corp. Investors

The Portnoy Law Firm has announced a class action lawsuit on behalf of Embecta Corp. (NASDAQ: EMBC) investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta made misleading statements regarding its fiscal guidance, particularly concerning weakness …

EMBC Class Reminder: Embecta Investors are Reminded of the Upcoming August 17 Deadline in the Filed Securities Fraud Class Action to Recover Losses

A securities fraud class action lawsuit has been filed against Embecta Corp. (EMBC) and its executives following a significant stock drop of over 57% on May 5, 2026. The lawsuit alleges that Embecta misled investors about the strength of its insulin pen needle product …

EMBC DEADLINE: The Gross Law Firm Reminds Embecta Corp. Investors of Upcoming Securities Class Action Deadline

The Gross Law Firm is reminding investors of Embecta Corp. (NASDAQ: EMBC) about an upcoming securities class action deadline of August 17, 2026. The lawsuit alleges that Embecta Corp. issued misleading statements regarding its fiscal results, specifically its pen needle business, leading to a …

EMBC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Embecta Corp. Investors Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Embecta Corp. (NASDAQ:EMBC) and its officers. The lawsuit alleges that Embecta made false and misleading statements regarding its business and prospects, specifically about its pen needle business, which led to a significant …

Kaplan Fox Urges Investors of Embecta Corp. (EMBC) with Significant Losses to Seek a Leadership Role Before August 17, 2026

Kaplan Fox & Kilsheimer LLP has initiated a class action lawsuit against Embecta Corp. (EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026, and suffered losses. The lawsuit stems from a significant drop in Embecta's stock price …

EMBC Stock Drop: If You Incurred Significant Losses in

Robbins LLP announced a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta misled investors regarding its business prospects, specifically by reaffirming revenue guidance for …

EMBC INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Embecta Corp. Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm

A class-action lawsuit has been filed against Embecta Corp. (NASDAQ: EMBC) alleging that the company made false and misleading statements and/or failed to disclose critical information regarding segment weakness, particularly in the U.S. pen needle market, which disrupted its revenue guidance and Q2 2026 …

EMBC Shareholder Alert: Embecta Corp. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased shares between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta's management concealed deteriorating conditions in the U.S. pen …